Claiborne Cary J 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Dec 8, 2021
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock options
2021-12-07+130,000→ 130,000 totalExercise: $2.77From: 2021-12-07Exp: 2031-12-08→ Common stock (130,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months.